Selective scalp block decreases short term post-operative pain scores and opioid use after craniotomy: A case series

2021 ◽  
Vol 93 ◽  
pp. 183-187
Author(s):  
Kunal S. Patel ◽  
Matthew Z. Sun ◽  
Shelby L. Willis ◽  
Mahlet Alemnew ◽  
Russell De Jong ◽  
...  
2021 ◽  
Author(s):  
Jonathan P Scoville ◽  
Evan Joyce ◽  
Joshua Hunsaker ◽  
Jared Reese ◽  
Herschel Wilde ◽  
...  

Abstract BACKGROUND Minimally invasive surgery (MIS) has been shown to decrease length of hospital stay and opioid use. OBJECTIVE To identify whether surgery for epilepsy mapping via MIS stereotactically placed electroencephalography (SEEG) electrodes decreased overall opioid use when compared with craniotomy for EEG grid placement (ECoG). METHODS Patients who underwent surgery for epilepsy mapping, either SEEG or ECoG, were identified through retrospective chart review from 2015 through 2018. The hospital stay was separated into specific time periods to distinguish opioid use immediately postoperatively, throughout the rest of the stay and at discharge. The total amount of opioids consumed during each period was calculated by transforming all types of opioids into their morphine equivalents (ME). Pain scores were also collected using a modification of the Clinically Aligned Pain Assessment (CAPA) scale. The 2 surgical groups were compared using appropriate statistical tests. RESULTS The study identified 43 patients who met the inclusion criteria: 36 underwent SEEG placement and 17 underwent craniotomy grid placement. There was a statistically significant difference in median opioid consumption per hospital stay between the ECoG and the SEEG placement groups, 307.8 vs 71.5 ME, respectively (P = .0011). There was also a significant difference in CAPA scales between the 2 groups (P = .0117). CONCLUSION Opioid use is significantly lower in patients who undergo MIS epilepsy mapping via SEEG compared with those who undergo the more invasive ECoG procedure. As part of efforts to decrease the overall opioid burden, these results should be considered by patients and surgeons when deciding on surgical methods.


2019 ◽  
Vol 7 (3_suppl) ◽  
pp. 2325967119S0011
Author(s):  
Elizabeth S. Liotta ◽  
Edward G. Schleyer ◽  
Mininder S. Kocher ◽  
Lyle J. Micheli ◽  
Benton E. Heyworth

Background: The culture of opioid abuse in the United States has brought attention to prescribing habits, especially as recent studies identify practices within the post-operative period as a risk factor for the development of opioid dependence in adolescents. The current study sought to explore the concept of post-operative pain control and opioid use following ACL reconstruction (ACLR), one of the most common orthopaedic procedures for adolescents. Because recent adult studies have suggested that use of quadriceps tendon autograft, a graft choice that appears to be growing in popularity, may be associated with lower post-operative pain scores than other graft sources, we additionally investigated an ACLR cohort who received quad tendon autograft (ACLR-Q) and compared their pain scores and opioid use to a cohort with the more commonly used hamstring tendon autograft (ACLR-HS). Methods: Between 2016 and 2018, patients aged 12-25 years who underwent primary ACLR-Q or ACLR-HS by one of three surgeons at tertiary care children’s hospital, were provided a journal to record daily subjective pain level and medication use. To avoid confounder or outliers, patients with a history of diagnosed clinical pain syndrome or underlying psychiatric condition were excluded. Logbooks contained a scale from ‘0-5’ to record pain level prior to each medication use and tables to record information detailing medication consumption. All patients were prescribed Oxycodone, 5 mg, for post-operative pain control. Patient demographics, surgical data, and prescription information were extracted from the electronic medical record. A two-sided t-test was used to evaluate statistical relationships of data between graft types. Results: Logbooks of 54 patients (27 ACLR-Q and 27 ACLR-HS) were collected for analysis. Both cohorts had a similar mean age at time of surgery (ACLR-Q: 16.7 years, range: 12-23; ACLR-HS: 16.8 years, range: 13-21), and preponderance of female subjects (ACLR-Q: 83.3%; ACLR-HS: 81.5%). The mean weight of patients who received the quadriceps tendon autograft (mean: 68.8lbs, range: 47-121) was slightly heavier than for patients who received the hamstring tendon autograft (mean: 62.0lbs, range 49-93), but not to a significant degree (p=0.084). More meniscal injuries were identified in ACLR-HS patients (77.8% vs. ACLR-Q: 48.1%, p=0.024), and treated with a repair procedure more commonly (81% vs. ACLR-Q: 46.2%, p=<0.001), than with meniscectomy (19%; ACLR-Q: 46.2%, p=0.282). Mean length of surgery and tourniquet time were longer in the ACLR-Q (129, 115 minutes) group than ACLR-HS group (80, 54 minutes) (p=<0.001; p=<0.001). While intra-operative nerve blocks were utilized by a similar proportion of both cohorts (ACLR-Q: 88.9%, ACLR-HS: 85.2%, p:0.692), the ACLR-Q group received more adductor canal blocks (89.9% vs. 14.8%, p: <0.001), while the ACLR-HS group received more femoral nerve blocks most frequently (ACLR-Q: 63% vs. 0%, p: <0.001). For the overall study population, the mean number of pills per Oxycodone prescription was 47.5 (range: 30-84). ACLR-Q patients consumed an average of 14.6 opioid pain pills (range: 3-46) over a mean of 13.7 doses (range: 3-36), with the last dose occurring on day 4.4 (range: 1-13). ACLR-HS patients consumed an average of 16.9 opioid pain pills (range: 0-39) over a mean of 14.0 doses (0-36), with the last dose occurring on day 3.7 (range: 0-13). There were no significant differences seen between number of pills consumed (p=0.387), number of doses (p=0.880), or number of days over which opioid medication was taken (p=0.364), between the two cohorts. Subjective pain experience was the same on day of surgery (DOS) for the two graft choices (score: 2.4). Average pain scores increased by the same amount on post-operative day 1 (score: 2.7) for both groups, likely as residual effects from regional anesthetic wore off. By post-operative day 3, average pain scores in the ACLR-Q group (score: 2.3) and ACLR-HS group (score: 2.0) had declined to less than that seen on DOS, without statistical difference (p=0.350) in the pain level between the cohorts. Conclusion/Significance: Despite longer tourniquet and operative times in the ACLR-Q group, which is likely reflective of graft harvest/preparation time and a surgical learning curve associated with a relatively newer technique, adolescents and young adults who received quadriceps and hamstring tendon grafts had a similar profile of subjective pain and use of post-operative opioid medication in the immediate post-operative period. Differing rates of concomitant meniscal injury and regional anesthetic techniques may represent confounding factors that warrant future studies controlling for such factors. Importantly, both reconstructive techniques resulted in a large surplus of unused opioid medication, furthering the notion that evidence-based prescription practices for post-operative care in different surgical techniques is warranted by orthopaedic surgeons and sports medicine physicians to help stem the rising tide of the opioid epidemic.


2013 ◽  
Vol 31 (15_suppl) ◽  
pp. e20673-e20673
Author(s):  
Laleh Azari ◽  
Sundae Stelts ◽  
Joseph T Santoso ◽  
Mehmet Kocak

e20673 Background: Hypomagnesemia is a common problem, occurring in nearly 12% of hospitalized patients. Due to the link of hypomagnesemia with surgery and the potential antinociceptive effects of Mg multiple trials have been conducted. Unfortunately, the role of IV and epidural Mg supplementation in pain management perioperatively remains controversial. An unanswered question from the literature to date is whether low serum Mg concentrations correlate with pain intensity. This review of patients undergoing gynecological surgeries examines whether pre-operative serum Mg level can affect pain scores and opioid use postoperatively. Methods: This was a retrospective study of the electronic medical record at Methodist University Hospital from October 1st, 2011 to July 31st, 2012. Included for analysis are all cases that underwent a gynecologic surgery and were performed under one attending surgeon. Each patient included in the study had perioperative serum Mg levels, resting and moving pain intensity scores, and amount of opioids used. Patients were excluded for any of the following criteria: missing data, discharge in less than 24 hours, robotic surgery, and use of ketamine in anesthesia. Statistical analysis included descriptive statistics, Spearman’s rank correlation coefficient, and logistic regression. Results: The analysis included 121 patients; 54% were Caucasian, the mean age was 51.7 years and 89% of surgeries were for oncologic indications. Pre-operative serum Mg level was not significantly associated with resting or moving pain intensity scores on post operative day (POD) 1 (p=0.66; p=0.68) or POD 2 (p=0.58, p=0.83). Pre-operative Mg level was not significantly associated with opioid use on POD 1 or 2. Two variables had a possible correlation with opioid usage, on average older patients used a lower level of opioid on average and patients with higher BMI used a higher level of opioids. Conclusions: Preoperative magnesium level has no correlation with pain scores or opioid use. While repletion maybe warranted and magnesium supplementation has minimal toxicity and cost, effect on post-operative pain is uncertain. Larger randomized trials may be warranted.


2020 ◽  
Vol 8 (7_suppl6) ◽  
pp. 2325967120S0050
Author(s):  
Ehab Nazzal

Objectives: Prescription opioid abuse continues to be a national crisis in the United States. Orthopaedic surgeons contribute significantly to this crisis, prescribing nearly a tenth of annual opioid prescriptions. With Anterior Cruciate Ligament (ACL) reconstruction being a common orthopaedic procedure performed at high volumes, understanding how physician opioid prescribing practices affects patient post-operative opioid utilization is of critical importance to curbing the orthopaedic contribution to the opioid epidemic. We aimed to assess how opioid tablet strength affects post-operative opioid consumption following ACL reconstruction. We hypothesized that prescribing a lower strength opioid tablet would not adversely influence post-operative pain or increase opioid consumption Methods: All data was collected prospectively from patients undergoing ACL reconstruction at a single academic ambulatory surgery center.All patients received the same peri-operative pain management protocol, which consisted of an adductor canal block at the time of surgery, Naprosyn 500 mg to be taken as needed, and pre-operative opioid education that outlined safe opioid use practice. Percocet was prescribed at two dosages in a consecutive fashion. Between March 2018 to October 2018, patients received Percocet at a strength of 7.5 mg (7.5 mg Oxycodone/325 Acetaminophen). From November 2018 to May 2019, patients received prescriptions at a dose of 5 mg. At the first post-operative clinic visit, patients completed a survey describing the quantity of opioid tablets consumed, days of postoperative opioid use, and opioid-related adverse effects. In addition, patients used a smart-phone application to assess post-operative pain on a numeric rating scale from post-operative day (POD) 1 to POD 6. Results: 148 patients were prospectively enrolled. 78 (51.3%) received Percocet at a strength of 7.5 mg per tablet and 69 (46.9%)received Percocet at a strength of 5 mg. The median age was 23 years (interquartile range: 18-36) and 49.7% were female. The 7.5 mg cohort took an average of 12.4 tablets (±7.0), while the 5 mg cohort took an average of 8.6 (±7.4) tablets, a 3.7 tablet decrease (p=0.002). Both cohorts consumed opioids for the same amount of post-operative days (5mg cohort: 3.1 days, 7.5mg cohort: 3.5 days; p=0.289). The incidence of opioid related side effect were equivalent between the 5 mg and 7.5 mg cohorts, which included constipation (34.8% and 34.6%, p=0.983), euphoria (5.8% v. 10.3%, p=0.324), nausea/vomiting (13.0% v. 16.7%, p=0.539), fatigue (2.9% v. 6.4%, p0.319), and pruritus (2.9% v. 5.1%, p=0.495). There was no difference in post-operative numeric pain scores in the 5 mg vs. the 7.5 mg cohort (POD 1: 5.7 ±1.9 vs. 5.4 ± 2.0, p=0.633; POD 6: 3.3 ± 2.1 vs. 2.9 ± 1.8, p=0.726). Conclusion: Prescribing a lower strength of oxycodone after ACL reconstruction did not increase pain scores or opioid consumption.This suggests that it is possible to achieve similar pain control while lowering the total opioid prescribed. These finding support future research focusing on optimizing pain control at minimal opioid doses.


2020 ◽  
Vol 16 (S2) ◽  
pp. 349-357
Author(s):  
George L. Caldwell ◽  
Michael A. Selepec

Abstract Background The use of opioid analgesia is common in both the acute and extended post-operative periods after rotator cuff repair. The current opioid crisis has prompted surgeons to seek alternatives that minimize or even eliminate the need for oral opioids after surgery. Questions/Purposes We sought to investigate the effects on post-operative opioid use of a surgeon-administered block of the suprascapular and axillary nerves in arthroscopic rotator cuff repair (ARCR), in particular to quantify outpatient opioid consumption and duration. Methods In this prospective observational study, all patients undergoing primary ARCR performed under general anesthesia by a single surgeon were studied over a 15-month period. Of 91 ARCRs performed, 87 patients were enrolled and followed prospectively. At the conclusion of the procedure, the surgeon performed “local–regional” nerve blockade with injections to the sensory branches of the suprascapular nerve and the axillary nerve, as well as local infiltration about the shoulder. Use of medications in the post-anesthesia care unit was left up to the anesthesiologist. Patients were prescribed oral opioids (hydrocodone/acetaminophen 5/325 mg) for analgesia after discharge. The quantity and duration of opioid use and pain scores were recorded for 4 months. Statistical analysis was performed to evaluate factors that could account for greater opioid use. Results Total opioid consumption ranged from 0 to 30 opioid tablets (average, 4.2 tablets) over the 4-month period. Post-operatively, 91% of patients took between ten or fewer tablets, and 39% took no opioids. The average duration of opioid use was 2.4 days. No patients were taking opioids at the 4- to 6-week or 4-month follow-up visits, none required refills, and none received prescriptions from outside prescribers. No statistically significant differences were seen in opioids taken or duration of use in regard to tear size, sex, body mass index, surgery location, or procedure time. There was a significant inverse correlation between opioid use and age. In addition, the cost of the surgeon-performed procedure was substantially lower than that associated with pre-operative nerve blockade performed by an anesthesiologist. All patients were satisfied with the post-operative pain management protocol. Average reported post-operative pain scores were low and decreased at each visit. Conclusion With this local–regional nerve-blocking protocol, opioid use after ARCR was unexpectedly low, and a large proportion of patients recovered without any post-surgical opioids. The correlation seen between opioid use and age may not be clinically significant, given the low use of post-operative opioids overall. These results may be useful in guiding post-operative opioid prescribing after ARCR, as well as in lowering costs associated with ARCR.


2020 ◽  
Vol 48 (2) ◽  
pp. 153-156
Author(s):  
Dijana Poljak ◽  
Joseph Chappelle

AbstractObjectiveThe primary objective was to evaluate if the administration of ibuprofen and acetaminophen at regularly scheduled intervals impacts pain scores and total opioid consumption, when compared to administration based on patient demand.MethodsA retrospective chart review was performed comparing scheduled vs. as-needed acetaminophen and ibuprofen regimens, with 100 women included in each arm. Demographics and delivery characteristics were collected in addition to pain scores and total ibuprofen, acetaminophen and oxycodone use at 24, 48 and 72 h postoperatively.ResultsThe scheduled dosing group was found to have a statistically significant decrease in pain scores at all time intervals. Acetaminophen and ibuprofen usage were also noted to be higher in this group while narcotic use was reduced by 64%.ConclusionScheduled dosing of non-narcotic pain medications can substantially decrease opioid usage after cesarean delivery and improve post-operative pain.


2018 ◽  
Vol 17 (03) ◽  
pp. 22-28
Author(s):  
Thong Q. Le

The objective of this study was to evaluate the efficiency of PU in male cats. The perineal urethrostomy (PU) was performed in 10 home-breed male cats, in which 9 cats were healthy and 1 cat had cystolith (2.5 ± 0.5 kg BW), from May 2017 to April 2018 at the Department of Clinical Veterinary Science of Nong Lam University, Ho Chi Minh City. The criteria for evaluating the experiment included the successful rate, wound healing time, post-operative pain assessment, time of return to normal urination and defecation and post-operative short-term complications. The results showed that 9 out of 10 cats completely recovered their urinating ability in approximately 14 days post-operation, in which 2 cats experienced wound infection and required a surgical intervention. One cat died due to unknown causes at the 10th day post operation. The average pain scores based on the Feline Glasgow Composite Measure Pain Scale (CMPS - Feline) in the first 5 days were relatively high (scored as 11) and gradually decreased; until 14 days post-operation, 100% of cats recovered had no sign of pain (scored as 1). It was recorded that all cats experienced pain and difficulty in urination and defecation for a few days after the surgery. After removing the urinary catheter, the cats needed 3 to 5 days to get used to the new urethral stoma and normally self-urinated ability. In general, the successful rate of this surgical method was 90% (9 out of 10 fully recovered cats) in which most of the cats were healthy and returned to normal urination after 14 days post-operation


2020 ◽  
Vol 26 (6) ◽  
pp. 1407-1414
Author(s):  
Arti Thakerar ◽  
Seamus Dines-Muntaner ◽  
Tijana Trifunovich ◽  
Marliese Alexander ◽  
Sonia Fullerton

Background Evidence for the use of short-term daily parenteral parecoxib for refractory or uncontrolled non-surgical cancer pain is limited. This study aimed to characterise the real-world off-label use and report on clinical experiences in an Australian cancer cohort. Methods Eligible patients received at least one dose of parecoxib of an intended three-day course between October 2015 and December 2018. Data were collected to characterise the parecoxib treatment cohort (cancer diagnosis, metastases, sites and types of pain and prior analgesia). Parecoxib-related adverse events, pain scores (worst and median), and concurrent opioid use were assessed at 24 h pre (T0) and 24 (T1), 48 (T2), 72 (T3) and 96 h (T4) post first parecoxib dose. Results Sixty-five patients (39 males and 26 females) and 68 courses of parecoxib (three patients treated twice) were included in analyses: metastatic disease (86%), bone pain (54%) and taking ≥3 classes of analgesic medications (69%). Pain types varied (46% non-specific, 22% neuropathic and 32% other). Most (94%) received parecoxib by subcutaneous administration. Following parecoxib, median 24-h pain scores and worst pain scores improved for 59% (40/68) and 50% (34/68) of patients, respectively. In the first 24 h (T0 to T1), median (4 vs. 2, p < 0.01) and worst (6 vs. 5, p < 0.01) pain scores were reduced and sustained to T4 (4 vs. 2.5, p = 0.01). Breakthrough analgesia requirements reduced for 63% (43/68) of patients, while total concurrent opioid use remained constant. Mean/median oral morphine equivalence for T0 vs. T1 was 111 mg/75 mg vs. 162 mg/90 mg, (p > 0.8). Two patients ceased parecoxib due to renal/liver function abnormalities and two experienced mild injection-site reactions. Conclusions In this real-world study, parecoxib was utilised as adjunctive therapy in a select patient cohort to contribute to reduced pain scores with no new safety signals. Prospective randomised studies in larger cohorts would improve understanding of the effects of parecoxib.


Author(s):  
Erica Holland ◽  
Daniel Low ◽  
Viviana Bompadre ◽  
Michael Saper

ObjectivesTo review the analgesic efficacy (by means of pain scores and opioid consumption) and adverse events after interscalene catheter (ISC) placement for ambulatory shoulder surgery in a series of adolescent patients.MethodsA retrospective review was performed of 36 patients who underwent ISC placement. Intraoperative and postoperative data regarding block placement, opioid consumption and pain scores were recorded. Via telephone, patients were assessed on postoperative days (PODs) 1-3 for pain scores, oxycodone use, global satisfaction and adverse effects of treatment.ResultsThe mean age was 15.4±1.8 years. The average time of ISC placement was 11.8±3.8 min. The mean postanaesthesia care unit maximum pain score was 1.6±2.4 with four patients who received rescue intravenous morphine. Mean pain scores for POD 1- 3 at rest were 2.5±2.3, 2.1±1.5 and 1.8±1.6, respectively. Mean number of doses of oxycodone on POD 1–3 were 1.1±1.4, 1.5±1.8 and 0.7±1.3, respectively. Satisfaction was reported in 94% of patients and 97% would have the catheter again. Adverse events included two accidental catheter removals at the end of the procedure or in the recovery unit, one catheter replacement at the end of surgery due to dislodgement, two early catheter removals on POD 2 because of dressing failure and insertion site discomfort, three cases of Horner’s Syndrome and one patient with transient ipsilateral facial numbness on POD 3.ConclusionThe use of ISCs in adolescent ambulatory shoulder surgery is beneficial, providing effective intraoperative and early postoperative analgesia as evidenced by low pain scores and minimal opioid use. Their routine use should be considered as they minimise perioperative opioid use with minimal adverse events.Level of evidenceLevel IV, case series.


Sign in / Sign up

Export Citation Format

Share Document